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In thehematopoietic stem cell hierarchy, the earliest cell is pluripotent andcapable
of extensive self-renewal (1) . Later cells have lesser amountsof self-renewal capacity
and a greater degree of differentiative commitment (1, 2). In humans, most studies
ofhematopoietic stem cellshave relied on assays of unipotent and multipotent colony-
forming cells (CFC),' populations that are relatively mature and capable of only
limited self-renewal . Recent data suggest that a less mature cell gives rise to CFC
in long-term marrow cultures (LTMC), and that cell surface antigens are markers
by which these primitive precursors can be distinguished .
Antigens expressed by different progenitor cell populations have been character-
ized in several laboratories (3-22) . Of particular interest aremAbs to the CD33 and
the CD34 antigens . Antibodies L4F3(5), L1B2(5), and MY-9(9) identify the CD33
antigen, while antibodies 12-8(6), MY10(10,11), BI-3C5(12-14), and ICH3(15) recognize
the CD34 antigen . The CD33 antigen is found on immature myelocytic cells in
marrow, whiletheCD34 antigen is only expressedby 1-4% ofmarrow cells . Impor-
tantly, both of the antigens are expressed by virtually all CFC (5, 6, 9-11, 13, 14) .
TheCD34 antigen also is expressed by cells that give rise to CFC during LTMC
(6), while the CD33 antigen is not (7).
In the studies presented here, we used mAbs to the CD33 and CD34 antigens
to separate cells on thebasis of expression ofCD33, CD34, andlight scattering prop-
erties . The ability of the cells to form colonies and generate CFC in LTMC was
assessed .
Materials and Methods
Bone Marrow Samples.
￿
Marrow samples were obtained from normal healthy donors fol-
lowing informed consent under an institutional review board approved protocol. RBC and
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mature granulocytic cells were depleted by density gradient centrifugation over Lymphocyte
Separation Medium (LSM) (sp gr 1.078; Litton Bionetics, Kensington, MD) at 400 g for
20 min at room temperature.
Antibody Preparation and Purification.
￿
The generation and characterization of the 12-8 and
L4F3 antibodies used in these experiments have been described in detail (5, 6) . Antibody
12-8 is a murine IgM mAb that identifies the CD34 antigen, an Mr 115,000 glycoprotein.
Antibody L4F3 is a murine IgM mAb that recognizes the CD33 antigen, an M, 67,000 gly-
coprotein. IgM mAbs were partially purified from ascites fluids by boric acid precipitation
as previously described (7). The p67-5 antibody is an IgG2a mouse mAb generated against
a transfected mouse cell line that expresses the CD33 antigen (22) (the FMY9S5C17 and
parental L-cell lines were kindly provided by Dr. T. Look, St. Jude's Research Hospital,
Memphis, TN). The p67-5 antibody competitively inhibits binding of L4F3 to the CD33
antigen (our unpublished observations). As isotype controls for staining we used the anti-mouse
Thy-1.1 mAb 1A14 (23), an IgG2a, and H12C12, a murine monoclonal IgM against the mouse
Thy-1.2 antigen.
Staining and Cell Sorting.
￿
Cells were stained using indirect immunofluorescent antibody
staining techniques and separated using FACS as previously described (5, 6). All staining
was done with cells suspended in sterile PBS supplemented with 2% human AB serum (Ir-
vine Scientific, Irvine, CA). For single-color fluorescence studies, 107 cells/ml were incubated
with antibody (25 pg/ml) for 30 min at 4°C, washed twice, and then incubated in a 1 :20
dilution of FITC-conjugated goat anti-mouse IgM (1, chain specific) antiserum (Tago Inc.,
Burlingame, CA) for 30 min at 4 °C.
For two-color staining, cells were incubated with both antibody 12-8 (25 Wg/ml) and p67-5
ascites (1 :103 dilution) . Control cells were incubated with: (a) H12C12 (25 Etg/ml) and 1A14
ascites (1 :103); (b) H12C12 (25 wg/ml) and p67-5 (1 :103); or (c) 12-8 (25 Fig/ml) and 1A14
(1 :103). Control and experimental cells were incubated with the primary antibodies for 30
min at 4°C, washed twice, then incubated with a 1 :80 dilution of biotin-conjugated goat
anti-mouse IgM antisera (u, chain specific; Tago, Inc.) and a 1 :20 dilution ofFITC-conjugated
goat anti-mouse IgG (y chain specific, Southern Biotechnology Associates, Inc., Birmingham,
AL.) for 30 min at 4°C, and then washed twice. Finally, cells were incubated with a 1 :20
dilution of phycoerythrin-conjugated avidin (Becton-Dickinson & Co., Oxnard, CA.) for 30
min at 4°C, and washed once. Cells were analyzed and sorted using either a FACS-440 or
FACS-II (Becton Dickinson & Go.). Cells were collected into RPMI-10% FCS.
The flow cytometers were set using fixed chicken red bloodcells and Calibrite beads (Becton
Dickinson & Co.) as standards for forward and right angle light scatter. Compensators and
photomultiplier tube voltage were set using a mixture of equal amounts of unconjugated,
FITC-conjugated, and PE-conjugated Calibrite beads. The compensators were adjusted so
that PE-labeled beadshad no more green fluorescence than unconjugated beads and the FITC-
labeled beads had the same red fluorescence as unconjugated beads.
Cytotoxicity Assays.
￿
Cells were treated with antibody and complement (C') in cytotoxicity
assays as previously described (5, 7). After the initial C' incubation, cells were pelleted, the
supernatant was removed, and cells were resuspended in C' (1 :4 dilution of rabbit serum)
and incubated for 60 min at 37°C. In one experiment, a third 60-min incubation with C'
was also performed. Residual viable cells were isolated by density gradient centrifugation
over LSM.
Colonyforming Assays.
￿
Progenitor cells capable of forming granulocytic and monocytic
(CFU-GM), erythroid (BFU-E), and mixed lineage (CFU-MIX) colonies were identified
by culturing cells in Iscove's modified Dulbecco's MEM (IMDM) (Gibco Laboratories, Grand
Island, NY) supplemented with 20% FCS (HyClone Laboratories, Logan, UT), 10% human
placental conditioned medium, 3 IU/ml human urinary erythropoietin (Terry Fox Cancer
Research Center, Vancouver, BC, Canada), 10-4 M 2-ME (Bio-Rad Laboratories, Rich-
mond, CA), and 0.3% agar (Seaplaque; FMC Corp., Rockland, ME). All cultures were in-
cubated at 37°C in 5% C02 in air, in a humidified incubator. At 14-16 d of culture the colo-
nies of different types were scored using an inverted microscope using the criteria for
identification of BFU-E and CFU-MIX as previously described (24).ANDREWS ET AL .
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Human placental conditioned medium was prepared using the methods of Schlunck and
Schleyer (25) and screened for the ability to support the growth in vitro of the desired types
of CFC .
Long-Term Marrow Cultures .
￿
Separated as well as unseparated marrow cells were cultured
in a long-term culture system previously described (6) . Irradiated adherent cell layers from
2-4-wk-old LTMC were used as "feeder layers" for isolated marrow cells (7) . Cells were inoc-
ulated onto irradiated layers and cultured for 5-7 d at 37°C, after which time cultures were
maintained in a 33°C incubator. At weekly intervals the cultures were fed by removing half
of the culture supernatant and replacing it with fresh medium . The nonadherent cells re-
moved with the culture supernatant were assayed for the presence of CFC .
Results
Positive Selection of CD34+ Cells After Lysis of CD33+ Cells.
￿
Marrow cells were
treated with the anti-CD33 antibody L4F3 and C'. In three experiments, L4F3 plus
C' lysed 93 t 1% (mean t SEM) ofCFU-GM, 82 t 4% ofBFU-E, and 95 ±
2% ofCFU-MIX, confirming that mostCFC express theCD33 antigen (5, 7) . Anal-
ysis by flow cytometry after lysis demonstrated that cells with high forward and high
right-angle light scatter characteristics were predominantly depleted (Fig . 1, A and
B), and that detectable numbers of CD33` cells were no longer present (Fig . 1 C) .
Antibody 12-8 stained 1.8-6.0% ofthe CD33-depleted cells (Fig . 1 D), representing
0.4-0.5% of marrow cells present before cytolysis .
We then separated the CD33- cells into CD34 + and CD34- populations by FRCS.
In a representative experiment (Fig . 2), the CD33-CD34+ cells produced unipo-
tent and multipotent CFC for more than 5 wk in LTMC (Fig. 2) . As expected, this
CD34+ fraction also contained the few CFC that remained after lysis with the anti-
CD33 antibody . In contrast, CD33 -CD34- cells in LTMC produced fewer CFU-
GM, and virtually no CFU-MIX or BFU-E . These results were confirmed in the
two additional experiments (data not shown) .
FIGURE 1 .
￿
(A and B) Bone marrow cells were analyzed by flow microfluorimetry for forward
and right angle light scatter characteristics before (A) and after (B) lysis with L4F3 and C' (anal-
ysis of 30,208 cells is shown in each panel). Cells with high right angle and forward light scat-
tering characteristics were predominantly depleted . (C and D) Viable cells isolated after lysis
with L4F3 + C' were analyzed for reactivity with mAbs L4F3 (C)and 12-8 (D) (analysis of6,000
cells is shown in each panel) . Antibody 12-8 positively stained 1.8% ofthe remaining cells, while
no detectable staining was observed with L4F3 or H12C12, theIgM control antibody (not shown) .
The dots representing positively stained cell populations in C andD have been enhanced for
purposes of reproduction .1724
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FIGURE 2.
￿
Long-term marrow cultures of CD34' and CD34- cells
resistant to lysis with L4F3 and C'. Data points are the cumulative
number of colonies produced from weeks 1-9 per 105 cells placed in
each LTMC at week 0. For each time point, the data are the mean
of two to four replicate cultures. Treatment with L4F3 + C' lysed
92 ± 1% ofCFU-GM, 100% of CFU-MIX, and83 t 17% ofBFU-
E. The remainingCD33- cells were 1.8 17o CD34* (see Fig. 1). The
CD34' and CD34- cells were separated by FRCS. At the initiation
of the LTMC the CD34' population contained 1,430 CFU-GM, 20
CFU-MIX, and 1,280BFU-E per 105 cells, andtheCD34- popula-
tion contained 3 CFU-GM, 0 CFU-MIX, and 220 BFU-E per 105
cells. (A) CFU-GM; (B) CFU-MIX; (C) BFU-E. (") CD34' cells;
(A) CD34- cells.
Direct Isolation of CD33-CD34' and CD33'CD34' Cells Using Two-Color Immunofluo-
rescence andCell Sorting. Cellswere labeled with the anti-CD34 and anti-CD33 anti-
bodies 12-8 and p67-5, respectively. The latter anti-CD33 antibody was used be-
cause it is of the IgG2aisotype and in two-color fluorescent antibody binding studies
it could be distinguished from the IgM antibody 12-8 by use of y- and /.-specific
second-step reagents (see Materials and Methods). Three groups of CD34+ cells
were isolated usingtwo-colorFACS. The first grouphadvirtually no detectable CD33
(fluorescence <99% of cells stained with p67-5 and <90% of control stained cells),
and represented 0.37c of all marrow cells analyzed and 12 17o of all CD34+ cells (Fig.
3). Most of these CD33-CD34+ cells had the appearance of small to intermediate
sized lymphocytes or small blast-like cells as determined by examinationof Wright-
stained slides prepared by cytocentrifugation. The third group was CD33+, with
fluorescence >95% of cells stained with the control antibody. These CD33'CD34'
FIGURE 3.
￿
Gated fluorescence histogramof
CD34' marrow cells, identified by staining
with antibody 12-8 simultaneously stained
with the anti-CD33 antibody p67-5 (solidline)
or with thecontrolantibody 1A14 (dotted line).
Fluorescence was analyzed on a FACS II
equipped with 5 log amplifiers for the pho-
tomultipliers. The cell number is displayed
usingalinear scale. Thevertical dashed lines
indicate the locations of sorting windows.
Movingfrom left to rightin thefigure: group
1, group II, and group III.cells accounted for 2.3% of marrow cells and 64% of the CD34' cells. The second
group contained CD34+ cells that had-fiCD33 expression intermediate between the
first and third groups (CD33). These accounted for 1% of marrow cells analyzed
and 27o7o of CD34+ cells. A fourth group consisting of CD34- cells also was col-
lected, and represented 96% of marrow cells analyzed.
When these groups were tested forcolony forming ability, the CD3.'PCD34' and
CD33*CD34' populations were found to contain ?90% of all CFC in the four sepa-
rated groups, and therefore in unseparated marrow as well.
Cells from these groups were grown in LTMC and the nonadherent cells tested
weekly for colony growth. The CD33 -CD34+ group was found to generate more
unipotent and multipotent CFC than did the CD33 +CD34+ population (Fig. 4),
while the CD33 1CD34+ cells generated intermediate numbers of CFC. Although
they constituted the majority of marrow cells, the CD34- cells generated virtually
no CFC. These findings were confirmed in two furtherexperiments(datanot shown).
Although the precursors of CFC were found in the CD33 -CD34+ population,
some CFC were still present in this group. To define a population of precursors de-
void of CFC activity, CD33-CD34+ cells were further fractionated on the basis of
light scatter properties.
Fractionation of CD33-CD34+ Cells by Light Scatter Properties.
￿
To study the light
scatterproperties ofprecursors ofCFC in LTMC we initially separated marrow cells
into subpopulations based solely on their right angle and forward angle light scat-
tering characteristics on the cell sorter. Four discrete populations of cells were de-
tectable (Fig. 5). Cells in the first population (A) had high right angle light scatter
and consisted primarily of morphologically maturing granulocytic and monocytic
ANDREWS ET AL.
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FIGURE 4.
￿
Long-term cultures ofmarrow cells isolated by two-color
immunolluorescent antibody staining and FAGS. Data points are the
cumulative number ofcolonies harvested from LTMC on weeks 1-6,
per 10,5 starting cells. For each time point the data are the mean of
two to four replicate cultures. At the initiation of cultures the colony
numbers per 105 cells were as follows: CD33+CD34* (group III, 64%
of CD34' cells) CFU-GM = 5,754, CFU-MIX = 80, BFU-E =
1,678; CD33'CD34' (Group II, 27% ofCD34' cells) CFU-GM =
4,745, CFU-MIX = 495, BFU-E = 5,245; CD33-CD34' (group
1, 12% of CD34' cells) CFU-GM = 3,466, CFU-MIX = 33, BFU-
E = 4,400; CD34- (group IV) CFU-GM = 19, CFU-MIX = 0,
BFU-E = 2. group I, CD33-CD34' ( "); group II, CD33'CD34'
(O); group III, CD33`CD34' (A); group IV, CD34- (A).1726
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FIGURE 5 .
￿
Light scatter analysis of unseparated Ficoll-
hypaque marrow cells (analysis of 60,416 events) is shown
as a two-dimensional representationofthe right angle,y-axis,
versus forward, x-axis, light scatter of unseparated bone
marrow cells, using linear amplification of signals is shown .
Thewindows used for sorting cells have been outlined and
labeled . (A) Cellswithhigh right angle light scatter (50.9%
of all events) ; (B) cells with low right angle and high for-
ward light scatter (2.7% of all events) ; (C) cells with low
right angle and low forward light scatter (17.5% ofall events) ;
and (D) cells with low right angleand very low forward light
scatter (11.1% of all events) .
cells . The second population (B) had cells with low right angle and high forward
light scattering andconsisted ofimmature monocytic cells andmyeloblastsmorpho-
logically. The third population (C) contained cellswith low right angle and low for-
ward light scattering properties . Morphologically these cells werelymphocyte sized
and had the appearance of mature lymphocytes and small blast cells . The fourth
population (Fig . 5 D) of cells had low right angle and still lower forward angle light
scattering and contained primarily nucleated and anucleate RBCs .
Cells from these four separatedpopulations were cultured directly to assaycolony
formation and cultured over irradiated marrow stromal cells in wells of microtiter
plates . In the direct colony assays the majority of colony forming cells were present
in the population of cells with low rightangleand high forward anglelight scattering
properties (Table I) . We then asked which population contained precursors forCFC
in LTMC . Cells from the long-term cultures were harvested after 4 wk of culture
and assayed forCFU-GM as a measure of generation ofCFC . The cultures of cells
with low right angle and low forward light scattering showed a 27-fold increase in
detectable CFU-GM . In contrast, the population that contained most of theCFC
in direct colony assays showed a nearly 50% decrease in detectable CFU-GM . The
cells with high right angle scatter and cells with light scatter properties of nucleated
RBC generated almost no CFU-GM in LTMC . This suggested that precursors of
CFC in LTMC should have the light scattering properties that would allow them
to be further distinguished in the CD33-CD34+ population .
The CD33 -CD34+ marrow cell population is heterogeneous primarily with re-
spect to forward angle light scatter characteristics.We therefore asked ifprecursors
of CFC in LTMC could be further distinguished within the CD33 -CD34+ popu-
lation based on light scattering characteristics . The CD33` cells were first depleted
by lysis with L4F3 and C', and the remaining CD34+ cells with low right angle light
scatter were separated into two populations by FAGS: one subset with low forward
light scatter, similar to that of lymphocytes, and a second subset with high forward
light scatter similar to that oflarger blast-like cells . The cellswith light scatter prop-ANDREWS ET AL.
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TABLE I
Separation ofMarrow Cells Based on Right Angle andForward
Light Scatter: Direct Colony Forming Activity and
Generation ofCFU-GM in LTMC
CFU-GM/105 cells
Light scatter
￿
Sort window`
High right angle
￿
A
Low right angle
High forward
￿
B
Low right angle
Low forward
￿
C
Low right angle
Very low forward
￿
D
￿
2 t 2
￿
3 t 4
Isolated cells were cultured directly in soft agar for the ability to form colo-
nies, and an identical number of each population was cultured in wells of
microtiter plates over irradiated marrow stromal cell layers . After4wk ofcul-
ture, all the cells in individual LTMC wells were harvested and cultured in
soft agar to assay for the presence ofCFU-GM. Data are expressed as the mean
t SEM of CFU-GM per 105 cells placed in culture, either directly in soft
agar or in the LTMC wells .
The sort windows are shown in Fig . 5.
erties similar to those of lymphocytes formed fewer CFU-GM upon direct culture
(0 colonies/10 5) than did cells with high forward light scatter (10 colonies/105) . Al-
though both populations of cells generated CFC in LTMC, the cells with low for-
ward light scatter generated fewerCFC in the first two weeks of LTMC than did
the cells with high forward light scatter (Fig. 6) . In contrast, after 4 wk of LTMC,
the cells with low forward light scatter generated greater numbers ofCFC than did
the cells with high forward light scatter. These resultswere confirmed in two further
studies (data not shown) . Thus, within the CD33 -CD34+ population it is possible
FIGURE 6 .
￿
CD33-CD34` cells with low right angle light
scatter were separated by FRCS into populations with low
forward or high forward light scatter. Data points areCFU-
GM in the nonadherent cell fraction per 2 x 10 6 LTMC
starting cells, and represent themean of two to four repli-
cate cultures at each time point. (Bottom)LTMC of cellswith
lowforward light scatter. (Top)LTMC ofcells with high for-
ward light scatter.
Direct culture Week 4 LTMC
2 ± 2 0
1,437 ± 52 807 ± 148
7 ± 3 190 ± 271728
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TABLE II
CFC from Long-Term Marrow Cultures of CD33- CD34' Cells:
Cytolysis with L4F3 (Anti-CD33 Antibody) And Complement
Data are the mean ± SEM for colonies at each time point, and are expressed
as total colonies per culture. HI2C12 is a control isotype matched mAb with
irrelevant specificity, anti-mouse Thy-1 .2 .
Percent lysis compared with control cultures.
to distinguish precursors ofCFC from cells with CFC activity on direct culturebased
on light scatter properties.
Expression ofthe CD33 Antigen by CFCfrom Long-Term Cultures of CD33- CD34' Mar-
row Cells. Ifthe CD33 antigen is acquired at the time ofdifferentiation to a CFC,
then CFC generated in LTMC from CD33-CD34' cells should express the CD33
antigen. We therefore tested the ability of L4F3 and C' to lyse CFC generated in
LTMC of CD33-CD34' cells, the CD34' cells isolated after lysis ofmarrow with
L4F3 andC' todepletecells expressing the CD33 antigen. The percent ofCFC from
these long-term cultures, that were sensitive to lysis by L4F3 and C' was similar to
that offresh marrow (Table II). These results were confirmed in two additional ex-
periments (data not shown) .
Discussion
The aim ofthe present studies was to provide direct evidence for the hypothesis
that precursors of CFC are distinguishable from CFC on the basis of expression
ofdifferentiation antigens. Data indicate that precursors ofCFC are separable from
CFC onthe basis ofexpression ofCD33 and CD34 antigens and physical properties.
Lysis ofCD33' marrow cells with antibody L4F3 and C' depleted 83-95,70 ofthe
CFC. Oftheremainingcells, thosethat expressed theCD34 antigen generated CFC
in LTMC. That the CD33-CD34' marrow cells contained the precursors for CFC
was demonstrated using two-color FRCS to directly isolate CD33-CD34' and
CD33'CD34' populations. In contrast, both the CD33 and CD34 antigens were
expressed on most CFC, and these CD33'CD34' cells lacked self-renewal capacity
in LTMC.
Importantly, as in fresh marrow, most CFC detected in LTMC ofCD33-CD34'
cells expressed the CD33 antigen as determined by lysis with antibody L4F3 and
C'(5, 7). This demonstrated that maturation ofCD33- cells to CFC in LTMC re-
sulted in the expression of the CD33 antigen.
Light scatter properties provided additional parameters for discriminating cells.
Most CFC had low right angle and high forward light scattering, while precursors
for CFC appeared to have low right angle and low forward light scattering proper-
ties. We used light scattering characteristics to discriminate CD33-CD34' cells with
different proliferative properties. It was then shown that cells requiring longer to
generate CFC in LTMC had the light scatterpropertiesofsmall lymphocytes, while
Week CFU-GM BFU-E CFU-MIX
5 L4F3 + C' 150 ± 52 (87)' 0 (100) 0(100)
H12C12+C' 1,180± 121 210+ 106 90+ 17
7 L4F3 + C' 10 ± 7 (98) 0(100) 0 (100)
H12C12 +C' 640±0 50± 7 100±0ANDREWS ET AL.
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cellswith high forwardlight scatter, associated with larger cells, generated CFC after
only a short time in LTMC . It is possible that these differences in light scatter, a
measure of cell size, reflect cells in different stages of the cell cycle or with differing
self renewal potential.
The importance of CD34+ marrow cells is underscored by our recent observa-
tions that the CD34 antigen also is expressed by a minor subset of baboon bone
marrow cells. These cells, when isolated by immunoadsorption chromatography and
FAGS can reconstitute lymphohematopoiesis in lethally irradiated baboons (26, 27),
while CD34- cells appear incapable of doing so (27). In initial clinical trials in pa-
tients with acute nonlymphoblastic leukemia (ANL), autologous marrow cellstreated
with an anti-CD33 mAb and C' to deplete ANL cells, which lysed nearly all CFC,
engrafted patients receiving marrow ablative chemoradiotherapy (our unpublished
observations; and Griffin, J. D., and J. Ritz, personal communication). These ob-
servations suggest that cells responsible for reconstituting hematopoiesis in vivo are
CD33 -CD34+.
An important unresolved question is whether CD33-CD34+ progenitors are
pluripotent and can generate lymphoid as well as myeloid progeny. In normal bone
marrow there are subsets ofCD34+ cells that express T cell-associated (CD2, CD7)
and B cell-associated (CD10, CD19, CD20) antigens, suggesting that CD34 is also
expressed by immature B and T lymphocytes (10, 12, 15, 28, 29, our unpublished
observations). Whether these cells, or CD34+ cells that do not express these lym-
phocyte-associated antigens canundergo lymphoid maturation cannot, however, be
determined until methods to culturehumanlymphoid precursorcells aredeveloped,
as they have been for murine cells (30-33). The presence of CD34 subpopulations
expressing lymphoid associated antigens also suggests that depletion of these cells
can allow further enrichment of precursors of CFC using methods as described in
the present studies.
Summary
We determined whetherhuman marrow cells that directly form colonies in vitro
could be distinguished from cells that generate or become CFC only after LTMC
in thepresence of irradiated marrow stromal cells. In previous studies, an anti-CD33
antibody, L4F3, and complement (C') were used to lyse nearly all CFC in marrow,
and the remaining cells generated CFC in LTMC. In the present studies, marrow
cells were treated with L4F3 + C' and the remaining CD33 - cells were separated
into CD34+ and CD34- populations and placed in LTMC . Only the CD34+ cells
were found to generate significant numbers of CFC. To compare the CD33-CD34+
and CD33 +CD34+ cells, we isolated each cell population using two-color FAGS.
Only LTMCs of the CD33-CD34+ cells generated CFC for >5 wk. In contrast, cells
that expressedboth theCD33 and CD34 antigens, whichcontainedmost ofthe CFC,
generated few CFC in LTMC . Fractionation of marrow cells based on right angle
and forward light scattering suggested that precursors for CFC have low right angle
and low forward light scattering properties. The CD33-CD34+ marrow cells were
therefore further fractionated based on light scatter characteristics. Cells with low
right angle andlow forwardlight scatterformed few or no colonies on direct culture,
yet generated greater numbers of CFC after 4 wk of LTMC than did cells with low
right angle and high forward light scatter. Most (87-98%) CFC generated in the1730
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LTMCs that were initiated with CD33 -CD34+ cells were found to express the
CD33 antigen. Thus, hematopoietic progenitors with differing proliferative and
differentiative potentials can be directly separated on the basis of their expression
of the CD33 and CD34 cell surface antigens and their light scatter properties.
Receivedfor publication 20 October 1988 and in revisedform 23 January 1989.
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